SEARCH

SEARCH BY CITATION

References

  • Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl 2): S1S209.
  • Arai Y, Takanashi H, Kitagawa H, Wirth KJ, Okayasu I (1999). Effect of icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice. Dig Dis Sci 44: 845851.
  • Bamias G, Cominelli F (2007). Immunopathogenesis of inflammatory bowel disease: current concepts. Curr Opin Gastroenterol 23: 365369.
  • Beck PL, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A et al. (2004). Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am J Physiol Gastrointest Liver Physiol 286: G137G147.
  • Ben-Neriah Y, Schmidt-Supprian M (2007). Epithelial NF-κB maintains host gut microflora homeostasis. Nat Immunol 8: 479481.
  • Bradford MM (1976). A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 74: 38053809.
  • Calixto JB, Cabrini DA, Ferreira J, Campos MM (2000). Kinins in pain and inflammation. Pain 87: 15.
  • Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM (2004). Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 143: 803818.
  • Campos MM, Leal PC, Yunes RA, Calixto JB (2006). Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. TIPS 27: 646651.
  • Cuthbert AW, MacVinish LL (1986). Transporting epithelia as targets for kinin effects. Adv Exp Med Biol 198A: 203210.
  • Cuthbert AW, Margolius HS (1982). Kinins stimulate net chloride secretion by the rat colon. Br J Pharmacol 75: 587598.
  • Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D et al. (2002). Pyrrolidine dithicarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 135: 496510.
  • Devani M, Vecchi M, Ferrero S, Avesani EC, Arizzi C, Chao L et al. (2005). Kallikrein–kinin system in inflammatory bowel disease: intestinal involvement and correlation with the degree of tissue inflammation. Dig Liver Dis 37: 665673.
  • El Sayah M, Medeiros R, Fernandes ES, Campos MM, Calixto JB (2006). Mechanisms underlying up-regulation in the pig iris sphincter in vitro. Mol Pharmacol 69: 17011708.
  • Fries W, Muja C, Crisafulli C, Cuzzocrea S, Mazzon E (2008). Dynamics of enterocyte tight junctions—effect of experimental colitis and two different anti-TNF strategies. Am J Physiol Gastrointest Liver Physiol 294: G938G947.
  • Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muià C, Esposito E et al. (2008). TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock 29: 3241.
  • Gougat J, Bernard F, Sarran L, Planchenault C, Poncelet M, Maruani J (2004). SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl] methylphenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin b1 receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther 309: 661669.
  • Hara DB, Fernandes ES, Campos MM, Calixto JB (2007). Pharmacological and biochemical characterization of bradykinin B2 receptors in the mouse colon: influence of the TNBS-induced colitis. Regul Pept 141: 2534.
  • Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C et al. (2005). Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128: 18051811.
  • Kamata K, Hayashi I, Mizuguchi Y, Arai K, Saeki T, Ohno T et al. (2002). Suppression of dextran sulfate sodium-induced colitis in kininogen-deficient rats and non-peptide B2 receptor antagonist-treated rats. Jpn J Pharmacol 90: 5966.
  • Kankuri E, Vaali K, Knowles RG, Lähde M, Korpela R, Vapaatalo H et al. (2001). Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. J Pharmacol Exp Ther 298: 11281132.
  • Leite DF, Echevarria-Lima J, Ferreira SC, Calixto JB, Rumjanek VM (2007). ABCC transporter inhibition reduces zymosan-induced peritonitis. J Leukoc Biol 82: 630637.
  • MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M et al. (1995). Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641650.
  • Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A (2005). The Kallikrein–kinin system: current and future pharmacological targets. J Pharmacol Sci 99: 638.
  • Ni A, Chao L, Chao J (1998). Transcription factor nuclear factor-κB regulates the inducible expression of the human B1 receptor gene in inflammation. J Biol Chem 273: 27842791.
  • Pesquero JB, Araujo RC, Heppentall PA, Stucky CL, Silva JA, Walther T et al. (2000). Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA 97: 81408145.
  • Phagoo SB, Poole S, Leeb-Lundberg LMF (1999). Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1β shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblast. Mol Pharmacol 56: 325333.
  • Rashid MH, Inoue M, Matsumoto M, Ueda H (2004). Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J Pharmacol Exp Ther 308: 11581164.
  • Rejdak K, Rejdak R, Sieklucka-Dziuba M, Stelmasiak Z, Grieb P (2001). 2-Deoxyglucose enhances epileptic tolerance evoked by transient incomplete brain ischemia in mice. Epilepsy Res 43: 271278.
  • Rocha AC, Fernandes ES, Passos GF, Calixto JB, Campos MM (2005). Assessment of TNF alpha contribution to the functional up-regulation of kinin B1 receptors in the mouse paw after treatment with LPS. Int Immunopharmacol 11: 15931600.
  • Rodrigues GB, Passos GF, Di Giunta G, Figueiredo CP, Rodrigues EB, Grumman A et al. (2007). Preventive and therapeutic anti-inflammatory effects of systemic and topical thalidomide on endotoxin-induced uveitis in rats. Exp Eye Res 84: 553560.
  • Rothe H, Ongören C, Rösen P, Kolb H (1993). Genetic analysis of aberrant tumor necrosis factor alpha production in prediabetic BB-rats. Transplant Proc 25: 28332834.
  • Scherrer D, Schmidlin F, Haddad E, Kassel O, Landry Y, Gies J (1999). Glucocorticoids increase bradykinin B2 receptor gene transcription in cultured guinea-pig tracheal smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol 359: 153159.
  • Shi X, Semkova I, Müther PS, Dell S, Kociok N, Joussen AM (2006). Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization. Exp Eye Res 83: 13251334.
  • Souza DG, Coutinho SF, Silveira MR, Cara DC, Teixeira MM (2000). Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats. Eur J Pharmacol 403: 121128.
  • Stadnicki A (2005). Tissue and plasma kallikrein in inflammatory bowel disease. Dig Liver Dis 37: 665673.
  • Stadnicki A, Gonciarz M, Niewiarowski TJ, Hartleb J, Rudnicki M, Merrell NB et al. (1997). Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis. Dig Dis Sci 42: 23552366.
  • Stadnicki A, Pastucha E, Nowaczyk G, Mazurek U, Plewka D, Machnik G et al. (2005). Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 289: 361366.
  • Stadnicki A, Sartor RB, Janardham R, Stadnicka I, Adam A, Blais C et al. (1998). Kallikrein–kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rat. Gut 43: 365374.
  • Steed PM, Tansey MG, Zalevsky J, Zhukovsky EA, Desjarlais JR, Szymkowski DE et al. (2003). Inactivation of TNF signaling by rationally designed dominant-negative TNF variants. Science 301: 18951898.
  • Van Limbergen J, Russell RK, Nimmo ER, Ho GT, Arnott ID, Wilson DC et al. (2007). Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis 13: 338355.
  • Van Rossum JM (1963). Cumulative dose–response curves. Arch Int Pharmacodyn 143: 299330.
  • Wallace JM, MacNaughton WK, Morris GP, Beck PL (1989). Inhibition of leukotriene synthesis markedly accelerates healing in rat model of inflammatory bowel disease. Gastroenterology 96: 2936.